Clinical Trials

Our clinic trial news comes directly from the U.S. National Institutes of Health.   If you have additional trial information please post it to our website or let us know by email.

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

Condition:   Type 2 Diabetes Nonalcoholic Fatty Liver
Interventions:   Dietary Supplement: caffeine and chlorogenic acid;   Dietary Supplement: caffeine;   Dietary Supplement: chlorogenic acid;   Dietary Supplement: placebo
Sponsor:   National Nutrition and Food Technology Institute
Not yet recruiting - verified October 2016

Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Condition:   Severe Aplastic Anemia
Interventions:   Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Network;   National Marrow Donor Program
Not yet recruiting - verified February 2017

Diagnosing Frontotemporal Lobar Degeneration

Conditions:   Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
Intervention:   Other: Observational Study
Sponsor:   University Health Network, Toronto
Recruiting - verified November 2016

Safety and Feasibility of the EyeControl Device

Condition:   ALS (Amyotrophic Lateral Sclerosis)
Intervention:   Device: EyeControl device
Sponsor:   Eyefree Assisting Communication Ltd
Active, not recruiting - verified February 2017

Pages